Form 8-K - Current report:
SEC Accession No. 0001437749-20-010423
Filing Date
2020-05-12
Accepted
2020-05-12 16:04:40
Documents
3
Period of Report
2020-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20200509_8k.htm 8-K 29430
2 EXHIBIT 99.1 ex_186330.htm EX-99.1 82827
3 ex_186330img001.jpg GRAPHIC 3882
  Complete submission text file 0001437749-20-010423.txt   119170
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 20869059
SIC: 2836 Biological Products, (No Diagnostic Substances)